QQ客服 官方微博 反馈留言

	CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma
	Chen, Xiang; Liu, Li; Wang, Jiajun; Lin, Zhiyuan; Xiong, Ying; Qu, Yang; Wang, Zewei; Yang, Yuanfeng; Guo, Jianming; Xu, Jiejie
刊名	UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
	2018
卷号	36期号:5
关键词	Metastatic renal cell carcinoma CXCR1 Tyrosine kinase inhibitors Prognosis Therapeutic response
ISSN号	1078-1439
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3609509
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Chen, Xiang,Liu, Li,Wang, Jiajun,et al. CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma[J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS,2018,36(5).
APA	Chen, Xiang.,Liu, Li.,Wang, Jiajun.,Lin, Zhiyuan.,Xiong, Ying.,...&Xu, Jiejie.(2018).CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma.UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS,36(5).
MLA	Chen, Xiang,et al."CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma".UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 36.5(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。